LifeScience Clinical & Diagnostic
SK Telecom Launches AI-Based Veterinary X-Ray Service 'X Caliber' in Australia
In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world ...
May 29, 2024 | News
Innovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to SevereInnovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to Severe Plaque Psoriasis
Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of canc...
May 28, 2024 | News
Guardant Health’s Shield™ Blood Test for Colorectal Cancer Screening Recommended for FDA Approval
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Molecular and Clinical Genetics Panel of...
May 27, 2024 | News
Aptamer Group Signs £465,000 Agreement for Development of Cervical Cancer Blood Test
Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...
May 22, 2024 | News
RemeGen Announces Completion of Patient Enrollment for Two Phase III Clinical Trials of Telitacicept in China
RemeGen Co. a commercial-stage biotechnology company, recently announced significant progress of Telitacicept (RC18), that two Phase III clinical tria...
May 22, 2024 | News
AstraZeneca Announces $1.5 Billion Manufacturing Facility in Singapore for Cutting-Edge Cancer Treatments
AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global s...
May 20, 2024 | News
Serum Institute of India Acquires 20% Stake in IntegriMedical to Accelerate Development of Needle-Free Injection Technology
- With this investment, SII will acquire 20% stake in IntegriMedical - ...
May 20, 2024 | News
Amplexd Therapeutics Secures $2 Million in Strategic Funding to Advance Non-Invasive Treatments for HPV-Induced Cervical Precancers
Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in acc...
May 20, 2024 | News
Amgen's IMDELLTRA™ Approved for Aggressive Lung Cancer
Amgen announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with e...
May 17, 2024 | News
A&D Invests $1M in Aevice Health to Expand Remote Respiratory Solutions
A&D Company, Limited has entered into a US$1M investment agreement with Aevice Health The collaboration is geared towards jointly expand...
May 15, 2024 | News
Arcellx and Kite Announce Phase 3 Trial for Anito-cel in Multiple Myeloma Patients
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMi...
May 10, 2024 | News
Formosa Pharmaceuticals Strikes Exclusive Licensing Deal with Tabuk for Innovative Eye Surgery Drug in MENA
Taiwan-based Formosa Pharmaceuticals announced that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing ...
May 10, 2024 | News
GHIT Fund Allocates JPY 1.64 Billion to Combat Malaria and Neglected Tropical Diseases Through Innovative Partnerships
The Global Health Innovative Technology (GHIT) Fund announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...
May 09, 2024 | News
Sciwind Biosciences and HK inno.N Forge Partnership to Bring New Diabetes Treatment to South Korea
Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation...
May 07, 2024 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
